Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2012 Nov 15;22(22):6839-43. doi: 10.1016/j.bmcl.2012.09.055. Epub 2012 Sep 24.

Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.

Author information

1
Chemical Biology Laboratory, National Cancer Institute, Frederick, MD 21702, United States. gildersj@mail.nih.gov

Abstract

Immunization with whole cells has been used extensively to generate monoclonal antibodies, produce protective immune responses, and discover new disease antigens. While glycans are abundant on cell surfaces, anti-glycan immune responses have not been well-characterized. We used glycan microarrays to profile 49 tumor-binding monoclonal antibodies generated by immunizing mice with whole cancer cells. A substantial proportion (41%) of the tumor binding antibodies bound carbohydrate antigens. The antibodies primarily recognize a group of 5 glycan antigens: Sialyl Lewis A (SLeA), Lewis A (LeA), Lewis X (LeX), blood group A (BG-A), and blood group H on a type 2 chain (BG-H2). The results have important implications for monoclonal antibody production and cancer vaccine development.

PMID:
23063402
PMCID:
PMC3478784
DOI:
10.1016/j.bmcl.2012.09.055
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center